{"id":194,"date":"2019-03-28T19:24:32","date_gmt":"2019-03-28T19:24:32","guid":{"rendered":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/?p=194"},"modified":"2025-05-27T19:47:31","modified_gmt":"2025-05-27T19:47:31","slug":"polyethylene-glycol-block-polydl-lactic-acid-micelles-containing-oligolactic-acid-8-paclitaxel-prodrug-in-vivo-conversion-and-antitumor-efficacy","status":"publish","type":"post","link":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/2019\/03\/28\/polyethylene-glycol-block-polydl-lactic-acid-micelles-containing-oligolactic-acid-8-paclitaxel-prodrug-in-vivo-conversion-and-antitumor-efficacy\/","title":{"rendered":"Poly(ethylene glycol)-block-poly(d,l-lactic acid) Micelles Containing Oligo(lactic acid) 8-paclitaxel Prodrug: In Vivo Conversion and Antitumor Efficacy"},"content":{"rendered":"<div class=\"publication-leader\">\r\n<div class=\"publication-date\">March 28, 2019<\/div>\r\n<a class=\"uw-button\" tabindex=\"0\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0168365919300926?via%3Dihub\">Cite this<\/a>\r\n\r\n<\/div>\r\n<div class=\"publication-primary-column\"><section class=\"content-components\"><section class=\"basic-text-block basic-text-block-width-full-width basic-text-block-position-left\">\r\n<div class=\"basic-text-block-region region\">\r\n<div class=\"basic-text-block-wrapper\">\r\n<h2 class=\"title\">Abstract<\/h2>\r\nPoly(ethylene glycol)-block-poly(d,l-lactic acid) (PEG-b-PLA) micelles affect drug solubilization, and a paclitaxel (PTX) loaded-PEG-b-PLA micelle (PTX-PM) is approved for cancer treatment due to injection safety and dose escalation (Genexol-PM\u00ae) compared to Taxol\u00ae. However, PTX-PM is unstable in blood, has rapid clearance, and causes dose-limiting toxicity. We have synthesized a prodrug for PTX (7-OH), using oligo(lactic acid) as a novel pro-moiety (o(LA)8-PTX) specifically for PEG-b-PLA micelles, gaining higher loading and slower release of o(LA)8-PTX over PTX. Notably, o(LA)8-PTX prodrug converts into PTX by a backbiting reaction in vitro, without requiring esterases. We hypothesize that o(LA)8-PTX-loaded PEG-b-PLA micelles (o(LA)8-PTX-PM) has a lower Cmax\u00a0and higher plasma AUC than PTX-PM for improved therapeutic effectiveness. In Sprague-Dawley rats at 10 mg\/kg, compared to o(LA)8-PTX-PM (10% w\/w loading) and PTX-PM (10%), o(LA)8-PTX-PM (50% w\/w loading) produces a 2- and 3-fold higher plasma AUC0-24\u00a0of PTX, lactic acid-PTX, and o(LA)2-PTX (o(LA)0-2-PTX), respectively. For o(LA)8-PTX-PM at 10 and 50% w\/w loading, PTX and lactic acid-PTX are major bioactive metabolites, respectively. Fast prodrug conversion of o(LA)8-PTX in vivo versus in vitro (by backbiting) suggests that o(LA)8\u00a0is a good substrate for esterases. At 60 mg\/kg (qwx3), o(LA)8-PTX-PM (50%) has higher antitumor activity than o(LA)8-PTX-PM (10%) and PTX-PM (10%) in a syngeneic 4T1-luc breast tumor model based on measurements of tumor volume, 4T1-luc breast tumor bioluminescence, and survival. Importantly, intravenous administration of o(LA)8-PTX-PM is well tolerated by BALB\/c mice. In summary, oligo(lactic acid)8-PTX is more compatible than PTX with PEG-b-PLA micelles, more stable, and may expand the role of PEG-b-PLA micelles from \u201csolubilizer\u201d into \u201cnanocarrier\u201d for PTX as a next-generation taxane for cancer.\r\n\r\n<img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-185\" src=\"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-content\/uploads\/sites\/41\/SOP.2017-Kwon-pub-cover-Polyethylene-glycol-300x169.jpg\" alt=\"image for depicting In Vivo conversion and antitumor efficacy\" width=\"630\" height=\"355\" srcset=\"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-content\/uploads\/sites\/41\/SOP.2017-Kwon-pub-cover-Polyethylene-glycol-300x169.jpg 300w, https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-content\/uploads\/sites\/41\/SOP.2017-Kwon-pub-cover-Polyethylene-glycol-768x432.jpg 768w, https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-content\/uploads\/sites\/41\/SOP.2017-Kwon-pub-cover-Polyethylene-glycol.jpg 800w\" sizes=\"auto, 100vw\" \/>\r\n\r\n<\/div>\r\n<h2>Cited by<\/h2>\r\nThis article is cited by 9 publications\r\n<ol class=\"list-of-citations show-all\" data-role=\"citations\">\r\n \t<li data-pubmed-id=\"37041376\">\r\n<div class=\"single-citation\">Repp, L., Skoczen, S. L., Rasoulianboroujeni, M., Stern, S. T., &amp; Kwon, G. S. (2023). Plasma Stability and Plasma Metabolite Concentration-Time Profiles of Oligo(Lactic Acid)8-Paclitaxel Prodrug Loaded Polymeric Micelles.\u00a0<i>The AAPS journal<\/i>,\u00a0<i>25<\/i>(3), 39.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.1208\/s12248-023-00807-4\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1208\/s12248-023-00807-4<\/a><\/div><\/li>\r\n \t<li data-pubmed-id=\"35988780\">\r\n<div class=\"single-citation\">Rasoulianboroujeni, M., Repp, L., Lee, H. J., &amp; Kwon, G. S. (2022). Production of paclitaxel-loaded PEG-b-PLA micelles using PEG for drug loading and freeze-drying.\u00a0<i>Journal of controlled release : official journal of the Controlled Release Society<\/i>,\u00a0<i>350<\/i>, 350\u2013359.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.032\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.032<\/a><\/div><\/li>\r\n \t<li data-pubmed-id=\"34685195\">\r\n<div class=\"single-citation\">Repp, L., Unterberger, C. J., Ye, Z., Feltenberger, J. B., Swanson, S. M., Marker, P. C., &amp; Kwon, G. S. (2021). Oligo(Lactic Acid)8-Docetaxel Prodrug-Loaded PEG-<i>b<\/i>-PLA Micelles for Prostate Cancer.\u00a0<i>Nanomaterials (Basel, Switzerland)<\/i>,\u00a0<i>11<\/i>(10), 2745.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.3390\/nano11102745\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.3390\/nano11102745<\/a><\/div><\/li>\r\n \t<li data-pubmed-id=\"34361634\">\r\n<div class=\"single-citation\">Cheng, M., Liu, Q., Gan, T., Fang, Y., Yue, P., Sun, Y., Jin, Y., Feng, J., &amp; Tu, L. (2021). Nanocrystal-Loaded Micelles for the Enhanced In Vivo Circulation of Docetaxel.\u00a0<i>Molecules (Basel, Switzerland)<\/i>,\u00a0<i>26<\/i>(15), 4481.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.3390\/molecules26154481\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.3390\/molecules26154481<\/a><\/div><\/li>\r\n \t<li data-pubmed-id=\"33754053\">\r\n<div class=\"single-citation\">Wan, J., Huang, L., Cheng, J., Qi, H., Jin, J., &amp; Wang, H. (2021). Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancer.\u00a0<i>Theranostics<\/i>,\u00a0<i>11<\/i>(9), 4137\u20134154.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.7150\/thno.54066\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.7150\/thno.54066<\/a><\/div><\/li>\r\n \t<li class=\"hidden\" data-pubmed-id=\"33096915\">\r\n<div class=\"single-citation\">Jin, I. S., Jo, M. J., Park, C. W., Chung, Y. B., Kim, J. S., &amp; Shin, D. H. (2020). Physicochemical, Pharmacokinetic, and Toxicity Evaluation of Soluplus\u00ae Polymeric Micelles Encapsulating Fenbendazole.\u00a0<i>Pharmaceutics<\/i>,\u00a0<i>12<\/i>(10), 1000.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.3390\/pharmaceutics12101000\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.3390\/pharmaceutics12101000<\/a><\/div><\/li>\r\n \t<li class=\"hidden\" data-pubmed-id=\"31374844\">\r\n<div class=\"single-citation\">Jo, M. J., Jo, Y. H., Lee, Y. J., Park, C. W., Kim, J. S., Hong, J. T., Chung, Y. B., Lee, M. K., &amp; Shin, D. H. (2019). Physicochemical, Pharmacokinetic, and Toxicity Evaluation of Methoxy Poly(ethylene glycol)-<i>b<\/i>-Poly(d,l-Lactide) Polymeric Micelles Encapsulating Alpinumisoflavone Extracted from Unripe\u00a0<i>Cudrania tricuspidata<\/i>\u00a0Fruit.\u00a0<i>Pharmaceutics<\/i>,\u00a0<i>11<\/i>(8), 366.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.3390\/pharmaceutics11080366\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.3390\/pharmaceutics11080366<\/a><\/div><\/li>\r\n \t<li class=\"hidden\" data-pubmed-id=\"30888509\">\r\n<div class=\"single-citation\">Tam, Y. T., Repp, L., Ma, Z. X., Feltenberger, J. B., &amp; Kwon, G. S. (2019). Oligo(Lactic Acid)8-Rapamycin Prodrug-Loaded Poly(Ethylene Glycol)-block-Poly(Lactic Acid) Micelles for Injection.\u00a0<i>Pharmaceutical research<\/i>,\u00a0<i>36<\/i>(5), 70.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.1007\/s11095-019-2600-0\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1007\/s11095-019-2600-0<\/a><\/div><\/li>\r\n \t<li class=\"hidden\" data-pubmed-id=\"31806973\">\r\n<div class=\"single-citation\">Gu, Y., Ma, J., Fu, Z., Xu, Y., Gao, B., Yao, J., Xu, W., Chu, K., &amp; Chen, J. (2019). Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy.\u00a0<i>International journal of nanomedicine<\/i>,\u00a0<i>14<\/i>, 8805\u20138818.\u00a0<a class=\"publication-link\" href=\"https:\/\/doi.org\/10.2147\/IJN.S210938\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.2147\/IJN.S210938<\/a><\/div><\/li>\r\n<\/ol>\r\n<\/div>\r\n<\/section><\/section><\/div>","protected":false},"excerpt":{"rendered":"March 28, 2019 Cite this Abstract Poly(ethylene glycol)-block-poly(d,l-lactic acid) (PEG-b-PLA) micelles affect drug solubilization, and a paclitaxel (PTX) loaded-PEG-b-PLA micelle (PTX-PM) is approved for cancer treatment due to injection safety and dose escalation (Genexol-PM\u00ae) compared &hellip;","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-194","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"_links":{"self":[{"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/posts\/194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/comments?post=194"}],"version-history":[{"count":2,"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/posts\/194\/revisions"}],"predecessor-version":[{"id":215,"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/posts\/194\/revisions\/215"}],"wp:attachment":[{"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/media?parent=194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/categories?post=194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wwwtest.pharmacy.wisc.edu\/faculty\/kwon-research-group\/wp-json\/wp\/v2\/tags?post=194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}